An Adaptative Randomized Phase II Study on the Timing of FOLFOX for Patients With Operable Stage III Rectal Cancer
This study is proposed to evaluate whether giving part of the chemotherapy prior to
radiation therapy and surgery (as opposed to standard of care, which involves giving all the
chemotherapy after radiation therapy and surgery) for patients with node positive operable rectal
cancer will result in higher patient compliance to chemotherapy.
View this trial on ClinicalTrials.gov
Print this page and take it to your doctor to discuss your eligibilty and treatment options. Only your doctor can refer you to a clinical trial.
These resources are provided in partnership with the
Canadian Cancer Society